ISOGENIX LIMITED
Significant control: Oxford Science Enterprises PLC (50–75%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Isogenix Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Isogenix Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
ISOGENIX LIMITED is an active private limited company (company number 14544942) incorporated on 16 December 2022, registered in Oxford. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of £885k and cash of £752k, with 4 employees on average. Net assets fell 62% on the prior period (£2.31m). Across the last 3 periods on record the net-asset trend is falling.
By net assets it sits in the top quarter of 152 comparable companies in Oxford (median £10k, upper quartile £474k).
Ownership and control
- Oxford Science Enterprises Plc
- owns 50–75% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
- Prof Matthew John Andrew Wood
- owns 25–50% of shares
- holds 25–50% of voting rights
- Carlo Rinaldi
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 16 December 20223 yrs ago
- Next accounts due
- 30 September 2027in 341 days
- Confirmation statement due
- 30 December 2026in 67 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £885k | £752k | £18k | £80k | — | — | 4 |
| 31 December 2024 | £2.31m | £2.16m | £251k | £187k | — | — | 4 |
| 31 December 2023 | £3.39m | £3.13m | £209k | £86k | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £884,975 at 31 December 2025
- Net assets down 25% or more on the prior period-61.8% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 9.65
- Cash at bank of £50,000 or moreCash £752,266
- Three or more accounting periods on record3 periods on record
- Incorporated two to five years agoIncorporated 16 December 2022
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 341 days
- Confirmation statement duein 67 days
- Accounts period endNet assets £885k · small accounts
- Accounts period endNet assets £2.31m · small accounts
- Accounts period endNet assets £3.39m · small accounts
- Incorporated
Similar companies in Oxford
- IUVANTIUM LIMITEDThame · inc. Dec 2022
- CAERULEUS GENOMICS LTDOxford · inc. Nov 2022
- YELLOWSTONE BIOSCIENCES LIMITEDOxford · inc. Jan 2023
- PENNINO CONSULTANT LTDAbingdon On The Themes · inc. Feb 2023
- VK CONSULT LTDOxford · inc. Feb 2023
- PTT BIO LIMITEDAbingdon · inc. Feb 2023
All companies incorporated on 16 December 2022 · in Dec 2022.
Reminders for ISOGENIX LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.